ES2077540A6 - Vitamin-mineral treatment methods and compositions - Google Patents

Vitamin-mineral treatment methods and compositions

Info

Publication number
ES2077540A6
ES2077540A6 ES09250030A ES9250030A ES2077540A6 ES 2077540 A6 ES2077540 A6 ES 2077540A6 ES 09250030 A ES09250030 A ES 09250030A ES 9250030 A ES9250030 A ES 9250030A ES 2077540 A6 ES2077540 A6 ES 2077540A6
Authority
ES
Spain
Prior art keywords
vitamin
compositions
treatment methods
composition
toxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09250030A
Other languages
Spanish (es)
Inventor
Joseph A Deihl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayor Pharmaceutical Laboratories Inc
Original Assignee
Mayor Pharmaceutical Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayor Pharmaceutical Laboratories Inc filed Critical Mayor Pharmaceutical Laboratories Inc
Priority to ES09250030A priority Critical patent/ES2077540A6/en
Priority claimed from EP96202765A external-priority patent/EP0754450A1/en
Priority claimed from AU10230/95A external-priority patent/AU680568B2/en
Publication of ES2077540A6 publication Critical patent/ES2077540A6/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmacological treatment method in which a spray composition is injected into the oral cavity in a multiplicity of aliquot doses during waking hours. The composition includes a soluble vitamin-mineral, a soluble flavoring agent and a non-toxic solvent for these compounds. In preferred embodiments the composition may include a non-toxic zinc compound, a combination of non-toxic zinc compound and Vitamin C, Vitamin A, or Vitamin B12.
ES09250030A 1990-10-16 1990-10-16 Vitamin-mineral treatment methods and compositions Expired - Fee Related ES2077540A6 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES09250030A ES2077540A6 (en) 1990-10-16 1990-10-16 Vitamin-mineral treatment methods and compositions

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP96202765A EP0754450A1 (en) 1990-10-16 1990-10-16 Vitamin-mineral treatment methods and compositions
PCT/US1990/005999 WO1992006726A1 (en) 1990-10-16 1990-10-16 Vitamin-mineral treatment methods and compositions
ES09250030A ES2077540A6 (en) 1990-10-16 1990-10-16 Vitamin-mineral treatment methods and compositions
CA002071837A CA2071837C (en) 1990-10-16 1990-10-16 Vitamin-mineral treatment methods and compositions
AU10230/95A AU680568B2 (en) 1990-10-16 1995-01-17 Vitamin-mineral treatment methods and compositions

Publications (1)

Publication Number Publication Date
ES2077540A6 true ES2077540A6 (en) 1995-11-16

Family

ID=36764056

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09250030A Expired - Fee Related ES2077540A6 (en) 1990-10-16 1990-10-16 Vitamin-mineral treatment methods and compositions

Country Status (1)

Country Link
ES (1) ES2077540A6 (en)

Similar Documents

Publication Publication Date Title
WO2000016762A3 (en) Method for reducing nicotine dependency
ES2004119A6 (en) Solid antitartar mouth deodorant composition
RU93042471A (en) COMPOSITIONS MASKING THE Bitter TASTE OF PHARMACEUTICAL AGENTS, METHOD FOR PRODUCING THEM, METHOD OF TREATMENT
NZ312715A (en) Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
UA27749C2 (en) Substituted cyclopropylamino-1,3,5-triazines, enantiomers, racemic mixtures or non-toxic, pharmaceutically acceptable acid addition salts thereof possessing pharmacological activity and process for the preparation thereof
CA2007181A1 (en) Sustained Release Pharmaceutical Composition
EP1258245A3 (en) Accelerated release composition containing bromocriptine
IL109186A0 (en) Stable, ingestable and absorbable nadh and nadph therapeutic compositions
HUT58058A (en) Insecticidal composition and process for producing its active ingredient, 1-phenylimidazole derivatives
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
PL324746A1 (en) Carbapenemic antibiotic composition and method of obtaining same
HUT65626A (en) Process for producing of acridinedione derivatives and pharmaceutical compositions comprising them
HUT53363A (en) Process for producing new perhydroazacycloalkano(1,2-a)imidazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
LV10256B (en) Novel acylale of imidazole-5-carboxylic acid derivatives, process for producing thereof and using same
CA2071837A1 (en) Vitamin-Mineral Treatment Methods and Compositions
MY104424A (en) Stereospecific process for the preparation of furo [3,4-c]pyridine enantiomers and compounds thus obtained
EP0292576A4 (en) Anti-ulcerous agent containing chalcone derivative as effective ingredient and novel chalcone derivatives
ES2077540A6 (en) Vitamin-mineral treatment methods and compositions
IL129231A0 (en) Process for preparing 2-azadihydroxybicyclo (2.2.1) heptane compounds and the l-tartaric acid salts of the compound
PL328123A1 (en) Derivatives of banzo[c]quinolysine and method of obtaining them
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
GR3022582T3 (en) Prophylactic and therapeutical preparation against caries.
UA62920C2 (en) Carbapeneme antibiotic, a composition and a method for the preparation
MD960294A (en) Method for prevention of the narrowing the the tubular walls of an animal, method for prevention of the human arterial restenosis, use of hyaluronic acid and forms thereof to prevent arterial restenosis, pharmaceutical composition on base of hyaluronic acid, salts, fragments and sub-units thereof

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20110302